scholarly journals Analysis of the Clinical Relevance of Histological Classification of Benign Epithelial Salivary Gland Tumours

2019 ◽  
Vol 36 (8) ◽  
pp. 1950-1974 ◽  
Author(s):  
Henrik Hellquist ◽  
António Paiva-Correia ◽  
Vincent Vander Poorten ◽  
Miquel Quer ◽  
Juan C. Hernandez-Prera ◽  
...  
2010 ◽  
Vol 3 ◽  
pp. CPath.S3303 ◽  
Author(s):  
Mari Markkanen-Leppänen ◽  
Antti A. Mäkitie ◽  
Fabricio Passador-Santos ◽  
Ilmo Leivo ◽  
Jaana Hagström

We report a rare case of bilateral basal cell adenocarcinoma (BcAC) of the parotid gland in a male patient 30 years after kidney transplantation and continuous administration of immunosuppressive therapy. BcAC is a salivary gland malignancy first recognized as a distinct neoplastic entity in WHO classification of salivary gland tumours in 1991. Over 90% of BcACs are detected in the parotid gland. The most important differential diagnosis is basal cell adenoma. Infiltrative growth is the distinguishing feature of BcAC. Administration of immunosuppressive medication to this patient for three decades may have contributed to development of this rare neoplasia. To our knowledge, similar cases of BcAC have not been reported previously.


2021 ◽  
Vol 14 (8) ◽  
pp. e244218
Author(s):  
Shiv Rajan ◽  
Ajay Kumar Singh ◽  
Sumaira Qayoom ◽  
Palavalasa Niranjan ◽  
Deep Chakrabarti

Polymorphous adenocarcinoma (PA) of the salivary glands is a rare malignancy that predominantly affects the minor salivary glands of the palate. Major salivary gland involvement is rare (<5%). The submandibular gland is a highly unusual location for this tumour. Recently, the WHO has updated the classification of salivary gland tumours in which the PA subtype has been modified. We report a very uncommon case of a classical variant of PA involving the submandibular gland in a 49-year-old woman managed at our institute and discuss the most recent pathological criteria for diagnosis, management strategy and prognosis of PA.


Sign in / Sign up

Export Citation Format

Share Document